Expertise in
39
conditions

Dr. Donald S. Gravenor

Oncology
Baptist Memorial Hospital Union County, Inc.
200 Hwy 30 W, 
New Albany, MS 
Accepting New Patients
Referral may be required
Before you request
Expertise in
39
conditions
Baptist Memorial Hospital Union County, Inc.
200 Hwy 30 W, 
New Albany, MS 

Overview

Donald Gravenor is an Oncologist practicing medicine in New Albany, Mississippi.

Dr. Gravenor is highly rated in 39 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Pleuropulmonary Blastoma, Familial Pancreatic Cancer, Paget Disease of the Breast, and Bone Marrow Aspiration.

He is actively involved in clinical research, co-authoring 4 peer reviewed articles and participating in 5 clinical trials. Dr. Gravenor is currently accepting new patients.

Specialties

Oncology

Licenses

Internal Medicine in MS

Hospital Affiliations

Baptist Memorial Hospital Union County
Baptist Memorial Hospital Tipton
Baptist Memorial Hospital Desoto
Dyersburg Regional Medical Center
Baptist Memorial Hospital

Languages Spoken

English
French

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Farm Bureau Health Plans
  • HMO
  • MEDICARE MAPD
  • MEDICARE PDP
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
HMO Partners
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Magnolia Health
  • HMO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 13 Less Insurance Carriers -

Locations

BAPTIST MEMORIAL HOSPITAL UNION COUNTY, INC.
200 Hwy 30 W, New Albany, MS 38652
Other Locations
BAPTIST MEMORIAL HOSPITAL-TIPTON
1700 Woodlawn Ave, Dyersburg, TN 38024

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Randomized Phase III Study of Nivolumab After Combined Modality Therapy (CMT) in High Risk Anal Cancer
A Randomized Phase III Study of Nivolumab After Combined Modality Therapy (CMT) in High Risk Anal Cancer
Enrollment Status: Active_not_recruiting
Publish Date: August 28, 2026
Intervention Type: Procedure, Biological, Other
Study Drug: Nivolumab
Study Phase: Phase 3
Molecular Analysis for Therapy Choice (MATCH)
Molecular Analysis for Therapy Choice (MATCH)
Enrollment Status: Active_not_recruiting
Publish Date: August 28, 2026
Intervention Type: Procedure, Drug, Other, Biological
Study Drugs: Adavosertib, Afatinib, Binimetinib, Capivasertib, Copanlisib, Crizotinib, Dabrafenib, Dasatinib, Defactinib, Erdafitinib, FGFR Inhibitor AZD4547, Ipatasertib, Larotrectinib, Nivolumab, Osimertinib, Palbociclib, Pertuzumab, PI3K-Beta Inhibitor GSK2636771, Sapanisertib, Sunitinib, Taselisib, Trametinib, Trastuzumab, Ulixertinib, Vismodegib
Study Phase: Phase 2
DART: Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors
DART: Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors
Enrollment Status: Active_not_recruiting
Publish Date: June 17, 2026
Intervention Type: Procedure, Biological
Study Drugs: Ipilimumab, Nivolumab
Study Phase: Phase 2
A Randomized Phase II Study of Ruxolitinib (NSC-752295) in Combination With BCR-ABL Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia (CML) Patients With Molecular Evidence of Disease
A Randomized Phase II Study of Ruxolitinib (NSC-752295) in Combination With BCR-ABL Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia (CML) Patients With Molecular Evidence of Disease
Enrollment Status: Active_not_recruiting
Publish Date: December 18, 2025
Intervention Type: Drug, Other
Study Drugs: Bosutinib, Dasatinib, Nilotinib, Nilotinib Hydrochloride Monohydrate, Ruxolitinib, Ruxolitinib Phosphate
Study Phase: Phase 2
Phase II/III Study of Circulating Tumor DNA as a Predictive Biomarker in Adjuvant Chemotherapy in Patients With Stage IIA Colon Cancer (COBRA)
Phase II/III Study of Circulating Tumor DNA as a Predictive Biomarker in Adjuvant Chemotherapy in Patients With Stage IIA Colon Cancer (COBRA)
Enrollment Status: Active_not_recruiting
Publish Date: May 07, 2025
Intervention Type: Drug, Other
Study Drugs: Capecitabine, 5-Fluorouracil, Leucovorin, Oxaliplatin
Study Phase: Phase 2/Phase 3
View 4 Less Clinical Trials

4 Total Publications

Avelumab in patients with previously treated metastatic melanoma: phase 1b results from the JAVELIN Solid Tumor trial.
Avelumab in patients with previously treated metastatic melanoma: phase 1b results from the JAVELIN Solid Tumor trial.
Journal: Journal for immunotherapy of cancer
Published: July 19, 2018
Similar Doctors
Expertise in
21
conditions
Expertise in
21
conditions
Referral may be required

The West Clinic PLLC

7945 Wolf River Blvd, 
Germantown, TN 
 (60.9 miles away)
901-683-0055
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Lee Schwartzberg is an Oncologist practicing medicine in Germantown, Tennessee. Dr. Schwartzberg is highly rated in 21 conditions, according to our data. His clinical expertise encompasses Breast Cancer, Agranulocytosis, Febrile Neutropenia, Paget Disease of the Breast, and Tissue Biopsy. Dr. Schwartzberg is currently accepting new patients.

Expertise in
12
conditions
Expertise in
12
conditions
Referral may be required

North Mississippi Medical Center Inc.

961 S Gloster St, 
Tupelo, MS 
 (25.2 miles away)
662-377-4550
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

John Straughn is an Oncologist practicing medicine in Tupelo, Mississippi. Dr. Straughn is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Ovarian Cancer, Endometrial Cancer, Cervical Cancer, Hernia Surgery, and Bladder Reconstruction. Dr. Straughn is currently accepting new patients.

Expertise in
133
conditions
Expertise in
133
conditions
Referral may be required

The West Clinic PLLC

2001 State Dr, 
Corinth, MS 
 (40.3 miles away)
662-286-3694
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

David Portnoy is an Oncologist practicing medicine in Corinth, Mississippi. Dr. Portnoy is highly rated in 133 conditions, according to our data. His clinical expertise encompasses Liposarcoma, Adult Soft Tissue Sarcoma, Rhabdomyosarcoma Embryonal, Retroperitoneal Liposarcoma, and Pancreaticoduodenectomy. Dr. Portnoy is currently accepting new patients.

Frequently Asked Questions about Dr. Donald S. Gravenor

How do I make an appointment with Dr. Donald S. Gravenor?

You can book an appointment with Dr. Donald S. Gravenor by calling their office at 601-534-7631. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Donald S. Gravenor a top-rated expert for Lung Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Donald S. Gravenor is classified as an Distinguished expert for Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Donald S. Gravenor specialize in?

While Dr. Donald S. Gravenor is a Oncology, they have specific expertise in Lung Cancer, Pleuropulmonary Blastoma, and Familial Pancreatic Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.

Does Dr. Donald S. Gravenor participate in research or clinical trials?

Yes. Dr. Donald S. Gravenor has published 4 articles and abstracts on conditions like Lung Cancer. You can view a list of Dr. Donald S. Gravenor's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Donald S. Gravenor accept my insurance?

Dr. Donald S. Gravenor accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 601-534-7631 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Gravenor's expertise for a condition
ConditionClose
    View All 34 Advanced Conditions
    View All 77 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile